The issue of certain infectious diseases of pregnant women in everyday practice
Part II. Viral infections

Czech version

Authors: J. Záhumenský ¹; V. Cupaník ²
Authors‘ workplace: Gynekologicko pôrodnícka klinika FN, Trnava, prednosta doc. MUDr. J. Záhumenský, Ph. D. ¹; Gynekologicko-pôrodnícka nemocnica Koch, Bratislava, riaditeľ MUDr. V. Cupaník, CSc. ²
Published in: Ceska Gynekol 2015; 80(4): 272-278

Overview

Object:
Authors in their text are bringing the latest published findings on the impact of some of the most common infectious diseases on the course and outcome of pregnancies.

Design:
Review.

Conclusions:
Recommendations for examination, treatment, and management of viral infection in pregnant women, especially from the view of a primary contact gynecologist.

Keywords:
pregnancy, infections, influenza, condylomatta accuminata, rubella, genital herpes, cytomegalovirosis, varicella, parvovirosis

Sources

1. Aaltonen, LM., Rihkanen, H., Vaheri, A. Human papillomavirus in larynx. Laryngoscope, 2002, 112, 4, p. 700–707.

2. Arena, S., Marconi, M., Ubertosi, M., et al. HPV and pregnancy: diagnostic methods, transmission and evolution. Minerva Ginecol, 2002, 54, 3, p. 225–237.

3. Bednarczyk, RA., Adjaye-Gbewonyo, D., Omer, SB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol, 2012, 207, 3, Suppl, p. S38–46.

4. Berardi, A., Lugli, L., Rossi, C., et al. Neonatal herpes simplex virus. J Matern Fetal Neonatal Med, 2011, 24, Suppl 1, p. 88–90.

5. Cannon, MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol, 2009, 46, Suppl 4, p. S6–10.

6. Cantu, J., Tita, AT. Management of influenza in pregnancy. Am J Perinatol, 2013, 30, 2, p. 99–103.

7. Ciavattini, A., Tsiroglou, D., Vichi, M., et al. Topical Imiquimod 5% cream therapy for external anogenital warts in pregnant women: report of four cases and review of the literature. J Matern Fetal Neonatal Med, 2012, 25, 7, p. 873–876.

8. Cobelli, KJ. Perinatal varicella. Pediatr Rev, 2013, 34, 1, p. 49–51.

9. Cohen, E., Levy, A., Holcberg, G., et al. Perinatal outcomes in condyloma acuminata pregnancies. Arch Gynecol Obstet, 2011, 283, 6, p. 1269–1273.

10. Coope, G., Connett, G. Juvenile laryngeal papillomatosis. Prim Care Respir J, 2006, 15, 2, p. 125–127.

11. Cosmi, E., Mari, G., Delle, CL., et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol, 2002, 187, 5, p. 1290–1293.

12. Daniilidis,. A, Sidiropoulos, K., Panna, ZD., et al. Association of fetal loss with recent parvovirus infection and other demographic prognostic risk factors. J Obstet Gynaecol, 2014, 34, 1, p. 0–44.

13. de Jong, EP., de Haan, TR., Kroes, AC., et al. Parvovirus B19 infection in pregnancy. J Clin Virol, 2006, 36, 1, p. 1–7.

14. Dodds, L., McNeil, SA., Fell, DB., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ, 2007, 176, 4, p. 463–468.

15. Dollard, SC., Grosse, SD., Ross, DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol, 2007, 17, 5, p. 355–363.

16. Enders, G., Bader, U., Lindemann, L., et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn, 2001, 21, 5, p. 362–377.

17. Enders, G., Daiminger, A., Bader, U., et al. Intrauterine trans-mission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol, 2011, 52, 3, p. 244–246.

18. Enders, M., Weidner, A., Zoellner, I., et al. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn, 2004, 24, 7, p. 513–518.

19. Farkas, N., Hoffmann, C., Ben-Sira, L., et al. Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection? Prenat Diagn, 2011, 31, 4, p. 360–366.

20. Furui, Y., Satake, M., Hoshi, Y., et al. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors. Transfusion, 2013, 53, 10, p. 2190–2197.

21. Greer, LG., Sheffield, JS., Rogers, VL., et al. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol, 2010, 115, 4, p. 711–716.

22. Guerra, B., Simonazzi, G., Puccetti, C., et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol, 2008, 198, 4, p. 380–381.

23. Hamouda, T., Freij, MA., Saleh, M. Management of genital warts in pregnancy. Clin Exp Obstet Gynecol, 2012, 39, 2, p. 242–244.

24. Holub, M., Aster, V., Roubalova, K., et al. [Recommendations for diagnosis and therapy of genital herpes in women]. Ces Gynek, 2009, 74, 4, p. 297–302.

25. Chisaka, H., Morita, E., Yaegashi, N., Sugamura, K. Parvovirus B19 and the pathogenesis of anaemia. Rev Med Virol, 2003, 13, 6, p. 347–59.

26. Jacquemard, F., Yamamoto, M., Costa, JM., et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG, 2007, 114, 9, p. 1113–1121.

27. Jamieson, DJ., Theiler, RN., Rasmussen, SA. Emerging infections and pregnancy. Emerg Infect Dis, 2006, 12, 11, p. 1638–1643.

28. Kenneson, A., Cannon, MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol, 2007, 17, 4, p. 253–276.

29. Kortekangas-Savolainen, O., Orhanen, E., Puodinketo, T., Vuorinen, T. Epidemiology of genital herpes simplex virus type 1 and 2 infections in southwestern Finland during a 10-year period (2003–2012). Sex Transm Dis, 2014, 41, 4, p. 268–271.

30. Kumar, SR., Biswas, M., Elankumaran, S. Pandemic H1N1 influenza a virus induces a potent innate immune response in human chorionic cells. Viral Immunol, 2014, 27, 3, p. 129–137.

31. Lassen, J., Bager, P., Wohlfahrt, J., et al. Parvovirus B19 infection in pregnancy and subsequent morbidity and mortality in offspring. Int J Epidemiol, 2013, 42, 4, p. 1070–1076.

32. Liesnard, C., Donner, C., Brancart, F., et al. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol, 2000, 95, 6 Pt 1, p. 881–888.

33. Lopaschuk, CC. New approach to managing genital warts. Can Fam Physician, 2013, 59, 7, p. 731–736.

34. Luteijn, JM., Brown, MJ., Dolk, H. Influenza and congenital anomalies: a systematic review and meta-analysis. Hum Reprod, 2014, 29, 4, p. 809–823.

35. Meijer, WJ., Wensing, AM., Bruinse, HW., Nikkels, PG. High rate of chronic villitis in placentas of pregnancies complicatedby influenza A/H1N1 infection. Infect Dis Obstet Gynecol, 2014, p. 768380.

36. Mertz, D., Kim, TH., Johnstone, J., et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ, 2013, 347, p. f5061.

37. Munoz, FM. Maternal immunization: an update for pediatricians. Pediatr Ann, 2013, 42, 8, p. 153–158.

38. Nabae, K., Satoh, H., Nishiura, H., et al. Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan. PLoS One, 2014, 9, 3, p. e92519.

39. Norbeck, O., Papadogiannakis, N., Petersson, K., et al. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis, 2002, 35, 9, p. 1032–1038.

40. Pembrey, L., Raynor, P., Griffiths, P., et al. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One, 2013, 8, 11, p. e81881.

41. Peng, TC., Searle, CR., Shah, KV., et al. Prevalence of human papillomavirus infections in term pregnancy. Am J Perinatol, 1990, 7, 2, p. 189–192.

42. Revello, MG., Lazzarotto, T., Guerra, B., et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med, 2014, 370, 14, p. 1316–1326.

43. Sauerbrei, A., Wutzler, P. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections. Med Microbiol Immunol, 2007, 196, 2, p. 95–102.

44. Shrim, A., Koren, G., Yudin, MH., Farine, D. Management of varicella infection (chickenpox) in pregnancy. J Obstet Gynaecol Can, 2012, 34, 3, p. 287–292.

45. Tongsong, T., Srisupundit, K., Traisrisilp, K. Prenatal sonographic diagnosis of congenital varicella syndrome. J Clin Ultrasound, 2012, 40, 3, p. 176–178.

46. Tuokko, H., Bloigu, R., Hukkanen, V. Herpes simplex virus type 1 genital herpes in young women: current trend in Northern Finland. Sex Transm Infect, 2014, 90, 2, p. 160.

47. Vyse, AJ., Andrews, NJ., Hesketh, LM., Pebody, R. The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect, 2007, 135, 8, p. 1354–1362.

48. Walker, SP., Palma-Dias, R., Wood, EM., et al. Cyto-megalovirus in pregnancy: to screen or not to screen. BMC Pregnancy Childbirth, 2013, 13, p. 96.

49. Westhoff, GL., Little, SE., Caughey, AB. Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections. Obstet Gynecol Surv, 2011, 66, 10, p. 629–638.

50. Yaegashi, N., Niinuma, T., Chisaka, H., et al. The incidence of, and factors leading to, parvovirus B19–related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect, 1998, 37, 1, p. 28–35.

51. Zahumensky, J., Vlacil, J., Holub, M., et al. Antiviral prophylaxis of neonatal herpes infection. Prague Med Rep, 2010, 111, 2, p. 142–147.

52. Zhang, HJ., Patenaude, V., Abenhaim, H. Maternal outcomes in pregnancies affected by varicella zoster virus infections. Obstet Gynecol, 2014, 123, Suppl. 1, p. 86S–87S.